KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to -$3.3 million.

  • Exact Sciences' Gains from Investment Securities rose 63.94% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 385.31%. This contributed to the annual value of -$3.3 million for FY2024, which is 81.46% up from last year.
  • As of FY2024, Exact Sciences' Gains from Investment Securities stood at -$3.3 million, which was up 81.46% from -$18.0 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' Gains from Investment Securities ranged from a high of $18.0 million in FY2021 and a low of -$56.6 million during FY2022.
  • Moreover, its 3-year median value for Gains from Investment Securities was -$18.0 million (2023), whereas its average is -$26.0 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 1,243.97% in 2020, then tumbled by 413.77% in 2022.
  • Exact Sciences' Gains from Investment Securities (Yearly) stood at $15.9 million in 2020, then grew by 13.15% to $18.0 million in 2021, then slumped by 413.77% to -$56.6 million in 2022, then spiked by 68.13% to -$18.0 million in 2023, then spiked by 81.46% to -$3.3 million in 2024.